[Frontiers in Bioscience E4, 2253-2268, January 1, 2012]
Physiological and pathophysiological functions of SOCE in the immune system
Patrick J. Shaw1, Stefan Feske1
1
TABLE OF CONTENTS
1. ABSTRACT
Calcium signals play a critical role in many cell-type specific effector functions during innate and adaptive immune responses. The predominant mechanism to raise intracellular (Ca2+) used by most immune cells is store-operated Ca2+ entry (SOCE), whereby the depletion of endoplasmic reticulum (ER) Ca2+ stores triggers the influx of extracellular Ca2+. SOCE in immune cells is mediated by the highly Ca2+ selective Ca2+-release-activated Ca2+ (CRAC) channel, encoded by ORAI1, ORAI2 and ORAI3 genes. ORAI proteins are activated by stromal interaction molecules (STIM) 1 and 2, which act as sensors of ER Ca2+ store depletion. The importance of SOCE mediated by STIM and ORAI proteins for immune function is evident from the immunodeficiency and autoimmunity in patients with mutations in STIM1 and ORAI1 genes. These patients and studies in gene-targeted mice have revealed an essential role for ORAI/STIM proteins in the function of several immune cells. This review focuses on recent advances made towards understanding the role of SOCE in immune cells with an emphasis on the immune dysregulation that results from defects in SOCE in human patients and transgenic mice.
2. INTRODUCTION TO STORE-OPERATED CALCIUM ENTRY BY STIM AND ORAI PROTEINS
The spatio-temporal regulation of intracellular calcium (Ca2+) concentrations (Ca2+)i is an important, conserved mechanism of signal transduction used by virtually all cell types including cells of the immune system (1-5). The engagement of various immunoreceptors such as antigen receptors on lymphocytes, Fc receptors on mast cells and macrophages or chemokine receptors on neutrophils results in a rapid increase in (Ca2+)i (2). This cytoplasmic Ca2+ elevation can be supplied by two sources: the release of Ca2+ from the endoplasmic reticulum (ER) or the influx of Ca2+ from the extracellular space. The emptying of ER Ca2+ stores is rapid but generally results in only a minor increase in (Ca2+)i as the volume of the ER is small in most immune cells. However, following ER Ca2+ store depletion, a secondary influx of extracellular Ca2+ through highly selective Ca2+ release activated Ca2+ (CRAC) channels in the plasma membrane results in a more substantial and sustained increase in cytosolic Ca2+ levels. This secondary Ca2+ influx downstream of ER Ca2+ stores is known as store-operated calcium entry (SOCE).
SOCE was postulated in 1986 (6) and measured in pancreatic acinar cells a few years later (7). The store-operated CRAC current (ICRAC) was identified soon after in mast cells and T cells (8-10). The proteins responsible for SOCE and ICRAC were not identified until 2005-2006 (11-15). These discoveries led to an exponential increase in studies describing SOCE and its role in cellular functions. SOCE is initiated when the ER Ca2+ stores are depleted, which is sensed by stromal interaction molecules (STIM) 1 and 2 (12, 13, 16). The STIM proteins are localized to the ER membrane, with their N-terminus extending into the ER and the C-terminus into the cytoplasm. Within the N-terminal region, STIM1 and STIM2 feature a pair of low affinity EF-hand Ca2+ binding domains. The decrease in the (Ca2+)ER results in the dissociation of Ca2+ from the EF-hand Ca2+ binding domains, a conformational change in the N terminus of STIM1 and STIM2 and their oligomerization (17). The kinetics of this conformational change and the resulting oligomerization are different for STIM1 and STIM2. The multimerization of STIM1 occurs significantly faster than that of STIM2, but the STIM1 aggregates are also more readily dissociated than STIM2 oligomers (18). In addition to differential expression of STIM1 and STIM2 in cell types, these differences in oligomerization dynamics likely account for the distinct roles of STIM1 and STIM2 in mediating SOCE. In T cells, STIM1 plays a dominant role in the initial, large influx of Ca2+ during SOCE, whereas STIM2 acts to maintain Ca2+ influx and mediates the homeostasis of resting Ca2+ levels (16, 19). The activation of the Ca2+ dependent family of nuclear factor of activated T cells (NFAT) transcription factors requires a prolonged increase in (Ca2+)i (16, 20), and therefore, at least in T lymphocytes, STIM1 and STIM2 both play a critical role in Ca2+/NFAT-dependent gene expression.
Once activated, STIM proteins translocate to sites where the ER membrane is in close proximity to the plasma membrane. There, STIM1 and STIM2 interact directly with ORAI proteins (ORAI1-3). ORAI proteins are tetraspanning membrane proteins, which are the pore-forming subunits of the CRAC channel located in the plasma membrane (21-23). The first transmembrane domain of ORAI1 contains several amino acid residues that line the ion channel pore (24, 25), of which glutamate 106 is of particular importance as it provides the binding site for Ca2+ ions inside the channel and imparts the high Ca2+ selectivity to the CRAC channel (21-23). ORAI proteins possess intracellular N- and C-termini that mediate binding to STIM1, STIM2 and potentially other proteins regulating CRAC channel function. Once activated, ORAI proteins mediate a sustained influx of extracellular Ca2+. This influx is dependent on an electrochemical concentration gradient that is generated by K+ channels and plasma membrane Ca2+ ATPases (PMCA) that provide a negative plasma membrane potential and maintain a low resting (Ca2+)i, respectively. ORAI1 and STIM1 are widely expressed in many cell types in humans and mice (26-30). ORAI1 is the best studied ORAI family member and critical for CRAC channel function in T cells, mast cells and several other types of immune cells. In addition, high levels of ORAI2 and ORAI3 mRNA are found in human CD19+ B cells and CD14+ monocytes, respectively (30), suggesting that these ORAI isoforms play a role in SOCE and potentially the function of these immune cells. The molecular composition of the CRAC channel, its structure and regulation by STIM proteins as well as its physiological function in many diverse tissues are an area of intense study the discussion of which is beyond the scope of this review (31, 32).
3. THE ROLE OF STIM1 AND ORAI1 IN IMMUNE CELL FUNCTION
An increase in (Ca2+)i is required for a variety of cellular immune functions. This section focuses on recent studies elucidating the role of SOCE and ORAI/STIM proteins in specific immune cell functions in vitro and in immune responses in vivo (Table 1). An emphasis is placed on studies using primary immune cells from mice and human patients lacking expression of functional ORAI and STIM genes.
3.1. Effector CD4+ T cells
Subsets of effector CD4+ T cells such as T helper (Th) 1, Th2 and Th17 cells produce cytokines such as IFN gamma IL-4 and IL-17, respectively, that are critical in mounting immune responses against pathogens (Table 1). SOCE in both human and murine CD4+ T cells is primarily mediated by STIM1 and ORAI1 following peptide-MHC binding by the TCR; in addition, binding of chemokines to their receptors can also trigger SOCE that requires STIM1 (11, 16, 33-36). While STIM1 mediates the fast activation of SOCE and the initial peak in (Ca2+)i, STIM2 was shown to be required for maintaining sustained Ca2+ influx following stimulation of CD4+ T cells (16).
SOCE mediated by ORAI1, STIM1 and STIM2 is dispensable for normal T cell development as the total number of T cells and the distribution of T cell subsets were normal in mice with targeted deletion of Orai1, Stim1, Stim2 and Stim1/Stim2 genes as well as human patients lacking SOCE due to mutations in ORAI1 and STIM1 genes (16, 29, 34-39). These findings suggest that the Ca2+ signals observed in immature T cells in the thymus (40, 41) are either not required for T cell development or may not be due to SOCE (mediated by ORAI1, STIM1 and STIM2). The depletion of ER Ca2+ stores resulting in low (Ca2+)i increases may be sufficient to promote T cell development. Alternatively, immature T cells may utilize non-store operated Ca2+ channels for Ca2+ signaling.
Although T cells develop normally in the absence of SOCE, their function is drastically impaired. The proliferation of T cells isolated from STIM1- and ORAI1-deficient patients was significantly reduced following in vitro stimulation with anti-CD3, antigens or mitogens (5, 29, 35, 42). This defect in T cell proliferation was also observed in murine lymphocytes lacking both Stim1 and Stim2 genes, but not in murine T cells lacking only Stim1 or Orai1 gene function (Orai1-/- or Orai1 knock-in (KI) mice, the latter expressing a nonfunctional ORAI1-R93W protein unable to mediate ICRAC) (16, 34, 36). Additionally, effector cytokine production by CD4+ T cell subsets was almost completely absent in SOCE-deficient T cells (16, 33, 34, 36, 38). In accordance with a critical role for SOCE in T cell function not just in vitro but also in vivo, fully MHC mismatched skin allografts from BALB/c mice transplanted onto C57BL/6 mice were tolerated significantly longer by ORAI1-deficient than wildtype mice (36). Since transplant rejection depends on both CD4+ and CD8+ T cells, this finding shows that SOCE is critical for allograft responses by CD4+ T cells (43). Similar observations were made in a model of acute graft-vs-host disease (GvHD) in which CD4+ T cells from Stim1-/- mice were injected (together with bone marrow) into irradiated BALB/c mice (34). While all mice that had received allogenic CD4+ T cells from Stim1-/- mice developed GvHD, only ~ 50% of mice succumbed to the disease in contrast to 100% of mice that had received wildtype CD4+ T cells.
SOCE plays a critical role in the function of all CD4+ T helper cell subsets. STIM1- and ORAI1-deficient Th2 cells have reduced IL-4 and IL-10 production in vitro and accordingly Th2-mediated contact hypersensitivity was completely absent in Orai1KI/KI mice (36). In the absence of SOCE, the production of IFN gamma and IL-2 by Th1 cells is decreased (16, 33, 34, 36, 38). Consequently, naive CD4+ T cells from STIM1- and ORAI1-deficient mice failed to induce inflammatory bowel disease (IBD) when transferred into lymphocyte-deficient hosts in contrast to T cells from wildtype mice, which caused severe colitis in recipient animals (36). In this model, IBD is primarily dependent on Th1 and Th17 cells (44), demonstrating a critical role for SOCE in Th1 and Th17 effector cell function in vivo.
Our studies suggest that the dependence of Th17 cells on SOCE is greater than that of other CD4+ T cell subsets. Murine CD4+ T cells lacking expression of Stim1 or Stim2 genes failed to produce IL-17A, IL-17F and IL-22 when isolated directly from mice or after culture for 3 days under Th17 polarizing conditions despite normal expression of ROR gamma t, a key transcription factor responsible for the differentiation of Th17 cells (33, 45, 46). As a result of impaired Th17 function, mice lacking Stim1 or Stim2 gene expression in T cells or all hematopoietic cells were resistant to induction of experimental autoimmune encephalomyelitis (EAE), a murine model of multiple sclerosis that is highly dependent on autoreactive Th17 cells (33, 46). Protection from EAE may also be due to the inability of STIM1-deficient Th17 cells to proliferate, a defect that was specific to Th17 cells and that was not observed in Th1 or Th0 cells (33). This dependence of Th17 cells on SOCE was also observed in vivo. When STIM1-deficient T cells were isolated from mice immunized with MOG peptide to induce EAE, restimulated and cultured under Th17 polarizing conditions in vitro and injected into lymphopenic host mice, they failed to expand in contrast to wildtype T cells (33). Impaired proliferation was also observed when STIM1-deficient T cells were co-injected with wildtype Th17 cells suggesting that this defect is intrinsic to SOCE-deficient Th17 cells (33). The molecular mechanisms underlying the SOCE dependence of Th17 cells is unknown, but could be due to the reduced expression of IL-23R on Th17 cells (33), which together with IL-23 is critical for the terminal differentiation and lineage stability of Th17 cells (47, 48). It was recently found that granulocyte macrophage colony stimulating factor (GM-CSF) production by Th17 cells is required to induce EAE (49, 50). Since GM-CSF production was dependent on IL-23, the decreased IL-23R expression in STIM1-deficient Th17 cells may contribute to their impaired ability to cause autoimmune CNS inflammation. Taken together, SOCE mediated by ORAI and STIM proteins is required for effector functions of Th1, Th2 and Th17 cells, in particular cytokine production, which are essential for host immune responses to pathogens and in autoimmune inflammatory processes.
3.2. Regulatory T cells
Regulatory T (Treg) cells are a suppressive subset of lymphocytes that play a critical role in maintaining immunological self-tolerance. Treg cell development and function require the transcription factor forkhead box P3 (Foxp3) (51). The importance of Foxp3+ Treg cells is evident in patients and mice with mutations in Foxp3 that abolish gene expression or Foxp3 function. Immunodysregulation polyendocrinopathy enteropathy X-linked (IPEX) syndrome in humans and the scurfy phenotype in mice (52, 53) are dominated by severe autoimmunity. Mice with conditional deletion of both Stim1 and Stim2 genes in T cells have significantly reduced Foxp3+ Treg populations in the thymus and secondary lymphoid organs indicating that Treg development requires SOCE (Table 1) (16). This requirement is intrinsic to Treg cells as mixed bone marrow chimeric mice (lymphopenic Rag2-/- mice which had received hematopoietic stem cells from congenically marked STIM1/STIM2-deficient and wildtype mice) also showed severely impaired Treg development (16). As a consequence, mice with T-cell specific deletion of Stim1 and Stim2 genes developed immunopathology in the form of lymphadenopathy, splenomegaly and inflammatory infiltration of internal organs such as lung and liver with lymphoid and myeloid cells (16). A defect in Treg development and autoimmunity was not observed in STIM1-deficient mice, suggesting that the contribution of STIM2 to SOCE in T cells is sufficient for Treg development (16, 34). ORAI1-deficient mice also had normal Treg development, presumably due to residual SOCE in naive CD4+ T cells which is likely to be mediated by ORAI2 and/or ORAI3 (29). Taken together, these findings indicate that the SOCE threshold required for Treg development is low and that only a complete lack of SOCE in STIM1- and STIM2-deficient mouse T cells is sufficient to interfere with Treg development (16).
SOCE is not only required for Treg development but also their suppressive function. Residual CD4+ CD25+ Foxp3+ Treg cells isolated from Stim1fl/fl Stim2fl/fl Cd4-Cre mice failed to suppress the proliferation of stimulated wildtype CD4+ T cells (16). By contrast, Treg cells from STIM1- and ORAI1-deficient mice showed only a moderate reduction in their suppressive activity compared to wildtype Treg cells, indicating that Treg cells require low levels of SOCE not only for their development but also for their function (34, 36). Nevertheless, CD4+ and CD8+ T cells isolated from spleen and lymph nodes of ORAI1-, STIM1- and especially STIM1/STIM2-deficient mice display an activated phenotype in vivo that is associated with a decrease in naive CD62Lhi T cells, an increase in CD44+ antigen-experienced memory T cells as well as lymphadenopathy and splenomegaly (16, 34, 36). This phenotype is likely to be due to, at least in part, impaired Treg function in vivo in the absence of Orai1, Stim1 or both Stim1 and Stim2 expression. Despite a significant reduction in the number and function of Foxp3+ Tregs in mice with T-cell specific deletion of Stim1 and Stim2 genes, their autoimmune inflammatory phenotype is less severe than that observed in Treg-deficient scurfy mice (54), which is likely due to the significantly impaired effector T cell function in STIM1/STIM2-deficient but not scurfy mice. Taken together, SOCE emerges to be a critical regulator of Treg development and function.
3.3. Cytotoxic lymphocytes
Cytotoxic lymphocytes, such as CD8+ T cells and NK cells, play a critical role in antiviral immune responses and tumor immunosurveillance through the killing of virus-infected and tumor cells, respectively. CD8+ T cells recognize antigen presented to them by MHC class I molecules via their T cell receptor resulting in the polarization and release of cytotoxic granules. Natural killer (NK) cells can attack a wide spectrum of target cells. Virus-infected cells, for instance, directly activate NK cell activating receptors such as Ly49H and NKp46 (55-57), whereas antibodies bound to target cell surface structures are recognized by low affinity Fc gamma receptors for IgG (CD16) on NK cells resulting in the release of cytotoxic granules and cytokines. An important role of SOCE in CD8+ T cells and NK cells can be inferred from the susceptibility of human patients with mutations in ORAI1 and STIM1 to severe viral infections (as will be discussed in more detail in chapter 4) (29, 35, 42, 58, 59).
Similar to CD4+ T cells, SOCE in CD8+ cells is predominantly mediated by STIM1 and ORAI1 following TCR stimulation (36, 38, 60). CD8+ T cells from patients with mutations in ORAI and STIM1 or STIM1/STIM2-deficient mice lack SOCE and CRAC channel function (16, 36, 38, 61). Residual Ca2+ influx and ICRAC are observed in naive CD8+ T cells from Orai1-/- and Orai1KI/KI mice. These are no longer present when CD8+ T cells are differentiated into cytotoxic T cells (CTL) in vitro, suggesting that the composition of the CRAC channel may change during CD8+ T cell differentiation (36, 38, 39). Whether this is also the case in human CD8+ T cells is unknown. Despite severely impaired SOCE in ORAI1- and STIM1-deficient mice and patients with mutations in ORAI1 and STIM1, the development of CD8+ T cells was unimpaired with normal numbers of CD8+ T cells in the blood, thymus and secondary lymphoid organs (16, 34-36, 42, 62). SOCE-deficient CD8+ T cells were, however, severely impaired in their ability to produce cytokines, especially IFN gamma, whereas expression of perforin and granzyme B, two enzymes required for cytotoxicity of CTL, was normal (Table 1) (16, 36). Human CD8+ T cells from a patient homozygous for the ORAI1-R91W mutation expressed significantly reduced amounts of many cytokine and chemokine genes including TNF alpha and IFN gamma (63), which are critical for antitumor and antiviral immune responses by CD8+ T cells. When treated with a pharmacologic inhibitor of SOCE, DPB162-AE (64), human CD8+ T cells exhibited impaired killing of tumor target cell in vitro (60). The cytotoxic function of CTL requires the exocytosis of lytic granules containing perforin and granzymes. This degranulation is dependent on SOCE and was found to be impaired in human and mouse CD8+ T cells lacking ORAI1 function (60). Consistent with the requirement for SOCE in CD8+ T cell function, Orai1KI/KI mice exhibited an impaired ability to reject tail skin transplants from histoincompatible donor mice (36).
NK cells, like CD8+ T cells, mediate antitumor and antiviral immune responses that require the production of cytokines such as IFN gamma and TNF alpha and direct, cell-mediated cytotoxicity via the release of cytolytic granules at the NK-target cell synapse. NK cells from patients with mutations in ORAI1 and STIM1 lacked SOCE in response to CD16 cross-linking or passive store depletion with thapsigargin indicating that SOCE in human NK cells is primarily mediated by STIM1 and ORAI1 (60). As a consequence, the production of IFN gamma and TNF alpha was severely compromised in the patients' NK cells when these were cocultured with tumor cells (60). As for CTL, the cytolytic function of NK cells requires the polarization and release of cytotoxic granules in response to target cell recognition (65). ORAI1- and STIM1-deficient human NK cells failed to degranulate as measured by CD107a surface expression and were almost completely incapable of killing tumor target cells in vitro (60). A similar if less pronounced defect in NK cell degranulation was observed in NK cells from Orai1KI/KI mice (SF and S. Ehl, unpublished). The significance of the functional defect observed in SOCE-deficient NK cells for immunity to viral infections in patients and mice is not well understood. In this context it is noteworthy that hematopoietic stem cell transplantation (HSCT) in an ORAI1-deficient patient resulted in partial immune reconstitution and his protection from severe infections although the patient's blood contained only 10-15% donor T cells and no donor NK cells (60). Taken together, STIM1 and ORAI1 mediate Ca2+ influx and the cytotoxic function of human and mouse CD8+ T cells and NK cells suggesting that SOCE is essential for antiviral and antitumor immune responses.
3.4. B cells
Antigen recognition by B cells through the B cell receptor (BCR) leads to the proliferation of B cells and their differentiation into antibody-secreting plasma cells. At the molecular level, BCR engagement results in the activation of tyrosine kinases such as Syk and Btk (Bruton's tyrosine kinase), phosphorylation of the scaffold protein BLNK (B cell linker protein), activation of PLC gamma 2 and emptying of ER Ca2+ stores. SOCE in B cells is dependent on STIM1 and ORAI1 as B cells from human patients with mutations in ORAI1 or STIM1 genes, Orai1-/- mice or mice with B-cell specific deletion of Stim1 and Stim2 lacked Ca2+ influx when stimulated through the BCR or by passive store depletion with thapsigargin (38, 42, 63, 66). A similar defect in SOCE was observed in DT40 chicken B cells lacking STIM1, whereas siRNA mediated suppression of ORAI1 had no effect on SOCE (67). SOCE is not required for B cell development as ORAI1 and STIM1-deficient patients and mice had normal numbers and subpopulations of B lymphocytes (Table 1) (16, 29, 35, 36, 38, 42, 66). Functionally, SOCE-deficient B cells showed a moderate decrease in proliferation in response to BCR cross-linking with anti-IgM antibodies, but not following lipopolysaccharide (LPS) stimulation confirming the important role of SOCE for BCR signaling (38, 66). By contrast, the serum levels of IgM, IgG and IgA were normal in ORAI1- and STIM1-deficient patients (29, 35, 42, 62), suggesting that SOCE is not required for B cell maturation and antibody production. Nevertheless, specific antibodies against vaccination antigens such as diphteria and tetanus toxoids or pathogens that patients had encountered previously such as C. albicans were absent in ORAI1- and STIM1-deficient patients (29). This lack of seroconversion is likely to be due to impaired T cell help for B cells rather than a B-cell intrinsic defect. These findings are consistent with normal T-cell independent (TI) and T-cell dependent (TD) antibody responses to immunization with 4-hydroxy-3-nitrophenyl (NP)-LPS and chicken gamma globulin (CGG), respectively, in mice with B-cell specific deletion of both Stim1 and Stim2 (66). T cells from these Stim1fl/fl Stim2fl/fl Mb1-Cre mice have normal SOCE allowing them to support TD antibody responses unlike T cells in ORAI1/STIM1-deficient patients whose T cells lack SOCE.
Expression of cytokines in B cells, like that in T cells, requires SOCE. IL-10 production was drastically reduced in splenic B cells from Stim1fl/fl Stim2fl/fl Mb1-Cre mice in response to LPS and anti-IgM stimulation (66). This defect is of particular importance for the function of a small subset of CD1dhiCD5+ regulatory B cells, which lacked IL-10 production. IL-10-producing B cells were found to have a protective role during T-cell induced CNS inflammation in EAE (68) and accordingly Stim1fl/fl Stim2fl/fl Mb1-Cre mice lacking IL-10 production showed excacerbated EAE. It is noteworthy that in contrast to Foxp3+ regulatory T cells, the numbers of regulatory B cells were normal. In addition, Stim1fl/fl Stim2fl/fl Mb1-Cre mice apparently did not spontaneously develop autoimmunity as a consequence of impaired regulatory B cell function, which is in contrast to Treg deficient Stim1fl/fl Stim2fl/fl Cd4-Cre mice. This is surprising insofar as STIM1 and SOCE were recently reported to regulate the Ca2+ dependent activation of the MAP kinase Erk in B cells undergoing negative selection during B cell development in the bone marrow (69). Overexpression of STIM1 in bone marrow stem cells had a proapoptotic effect and resulted in the loss of those developing B cells that recognized self-antigen during negative selection. If mice lacking Stim1 and Stim2 expression in B cells had a significant defect in negative selection, one would expect an autoimmune phenotype in these mice, which has not been reported (66). It is possible that negative selection is unaffected in Stim1fl/fl Stim2fl/fl Mb1-Cre mice because STIM1 and STIM2 protein levels are not fully depleted during negative selection (which takes place in immature IgMlo B cells), although Mb1-driven Cre expression occurs after the ProB cell stage and therefore precedes negative selection. Alternatively, it is possible that the proapoptotic effect of STIM1 is only observed under conditions of STIM1 overexpression but does not occur at physiological STIM1 levels, explaining why STIM-deficient mice showed no apparent signs of impaired negative selection. Taken together, SOCE in B cells appears to be largely dispensable for the development of B cells as well as antibody production, but is required for IL-10 expression and the function of regulatory B cells.
3.5. Dendritic cells
Dendritic cells (DC) are a heterogenous population of immune cells, whose primary function is to present pathogen-derived antigens to T cells and to provide them with costimulatory signals. Immature DC in peripheral tissues take up antigen, process and load it onto MHC class II molecules, and present it to T cells following their migration to lymph nodes. DC mature into fully functional antigen presenting cells (APC) after having received additional activation signals in the context of infection or inflammation (e.g. viral RNA, LPS, stimulation through CD40 on the DC cell surface). Ca2+ signaling is required for a number of dendritic cell functions including maturation, apoptotic body engulfment and migration (70-72). Ca2+ influx in murine myeloid DC is predominantly mediated by SOCE in response to LPS, ATP or thapsigargin stimulation (73, 74). Ca2+ currents recorded in these cells had biophysical properties similar to those of ICRAC and could be blocked by SKF 96365, a non-specific inhibitor of Ca2+ channels (73, 74). Which ORAI and STIM proteins are responsible for SOCE in DCs remains to be elucidated but one recent study suggested that SOCE in murine bone-marrow derived DCs is mediated primarily by ORAI2 and STIM2 (but not STIM1) (75). Nevertheless, SOCE is required for various DC functions (Table 1). Expression of the DC maturation markers CD80, CD86 and MHC class II was enhanced following induction of SOCE by thapsigargin or LPS treatment and inhibited by SKF-96365 (73, 74). In addition, the expression of the proinflammatory cytokines TNF alpha and IL-6 by DCs and their chemotactic migration in vitro in response to CCL21 were impaired in the presence of SKF-96365 (73). Since SKF-96365 is not a selective CRAC channel inhibitor, further studies are required to assess the contribution of ORAI and STIM proteins to DC function and immune responses in vivo.
3.6. Mast cells
Mast cells play an important role at the interface of innate and adaptive immunity and contribute to immune responses to bacterial and viral infections (76-78). However, mast cells can also be injurious and act as the central mediator of immediate hypersensitivity reactions and allergic diseases. The primary mechanism of mast cell activation is through the crosslinking of high affinity IgE receptor (Fc epsilon RI) by multivalent antigens. Mast cell activation results in degranulation and the production and release of proinflammatory lipids and cytokines. Murine mast cells lacking either Stim1 or Orai1 expression exhibited severely impaired SOCE in response to antigen-mediated Fc epsilon receptor I crosslinking or thapsigargin treatment (37, 39). The development of SOCE-deficient mast cells, their proliferation, morphology and Fc epsilon receptor I expression were normal compared to wild-type mast cells. However, antigen-dependent mast cell degranulation was reduced in SOCE-deficient mast cells (37, 39), similar to SOCE-deficient CTLs (Table 1). The rearrangement of microtubules, required for cellular degranulation and Ag-dependent mast cell motility, was found to be dependent on SOCE, and drastically reduced in STIM1-deficient mast cells (79). Additionally, the Fc epsilon RI-dependent production and release of proinflammatory cytokines IL-6, TNF alpha and IL-13 required STIM1 and ORAI1 (37, 39). Based on the role of SOCE in mast cell functions in vitro, Fc epsilon receptor-induced mast cell-mediated passive cutaneous anaphylaxis in vivo was abolished in ORAI1-deficient mice and strongly reduced in Stim1+/- mice (37, 39). The reduced anaphylactic response in Stim1+/- mice suggests that even a moderate reduction in SOCE significantly impairs mast cell effector functions. Future studies will show whether the SOCE dependence of mast cell function can be exploited therapeutically to alleviate atopic diseases such as allergic asthma.
3.7. Macrophages
Macrophages constitute one of the first lines of immune defense against pathogens. Their main functions include the phagocytosis of cell debris and pathogens, and the production of cytokines such as IL-1 beta, IL-6 and IL-12, which allow them to signal to other immune cells and activate immune responses. Recognition of antibody-opsonized pathogens by macrophages occurs via Fc gamma receptors on their cell surface. Fc gamma receptor crosslinking in macrophages causes SOCE that is dependent on STIM1 as Ca2+ influx was severely impaired in F4/80+ peritoneal macrophages isolated from Stim1-/- mice that were stimulated with thapsigargin or Fc gamma receptor II/IIIa crosslinking (80). The lack of Stim1 expression did not interfere with the development of monocytes and their differentiation into macrophages. An increase in (Ca2+)i was shown to be required for several macrophage functions, for instance the respiratory burst resulting in the generation of reactive oxygen species (ROS), nitric oxide production, secretion of microbicidal granules and synthesis of proinflammatory mediators (81-83). In addition, a rise in (Ca2+)i has been implicated in phagosome maturation, a process during which phagosomes containing ingested pathogens fuse with lysosomes in order to kill the pathogen. Several studies have shown that a rise in (Ca2+)i is required for phagosome-lysosome fusion (84-86), whereas other groups reported that this process is Ca2+ independent (87) or inhibited by an increase in intracellular calcium (88).
The most direct evidence for a role of SOCE in macrophage function comes from studies in Stim1-/- mice (Table 1). The production of cytokines such as MIP-2 and TNF alpha by STIM1-deficient macrophages in response to Fc gamma receptor crosslinking was only moderately impaired (80). By contrast, SOCE-deficient macrophages showed significantly reduced IgG2a and IgG2b mediated phagocytosis of opsonized red blood cells (80). Accordingly, STIM1-deficient mice were resistant to the induction of hemolytic anemia and thrombocytopenia in murine models of autoimmune disease following the binding of antibody-opsonized red blood cells and platelets to Fc gamma receptors on macrophages and their phagocytosis (80). Stim1-/- mice were also protected from developing immune complex-mediated pneumonitis which is mediated by tissue resident macrophages in the lung following binding of circulating immune complexes (IC) to their surface Fc gamma receptors (80). STIM1-deficient macrophages failed to infiltrate lung alveoli and to cause hemorrhage, which has been attributed to the impaired production of the vasoactive complement factor C5a. It is noteworthy that in contrast to Stim1-/- mice, STIM1 deficient patients were not protected from autoimmune hemolytic anemia and thrombocytopenia which was associated with the presence of anti-erythrocyte and anti-platelet autoantibodies (35). The cause for this discrepancy between human and mice is unknown. Further studies are required to elucidate, for instance, the role of SOCE for the function of tissue resident macrophages in the liver, CNS and other tissues and the ability of infected macrophages to promote phagosome maturation and to kill intracellular pathogens.
3.8. Neutrophils
Neutrophils, like macrophages, are first line responders to many infections. Neutrophils recognize antibody-opsonized pathogens and immune complexes (IC) containing antigens and antibodies via Fc gamma receptors on their cell surface. This results in the phagocytosis and destruction of pathogens and IC in the phagosome in a process that requires the production of reactive oxygen species (ROS) such as O2- and H2O2. Ca2+ influx in neutrophils is the result of crosslinking of Fc gamma receptors IIa and IIIb or binding of chemokines such as IL-8 and formyl Met-Leu-Phe (fMLP) to their receptors (89). Ca2+ influx in neutrophils is mediated by SOCE through ORAI1 and STIM1 as fMLP or thapsigargin induced Ca2+ levels were reduced in neutrophils from Orai1+/- mice and in the HL60 neutrophil cell line following the attenuation of ORAI1 and STIM1 expression by siRNA (90, 91). Furthermore, Ca2+ influx was absent in neutrophils from immunodeficient patients (42) that were later identified to lack ORAI1 protein expression (29). The numbers of polymorphonuclear cells including neutrophils, basophils and eosinophils in this and other ORAI1/STIM1 patients were normal suggesting that SOCE is not required for granulocyte development (29, 35, 42). Increases in (Ca2+)i and SOCE in response to Fc gamma receptor and chemokine signals are, however, essential for neutrophil function (Table 1). This was recognized long before ORAI1 and STIM1 were identified as both phagocytosis of pathogens and the production of ROS, for instance, were shown to be dependent on Ca2+ influx (89, 92-94). ROS in neutrophils are generated by NADPH oxidase 2 (NOX2), a multiprotein enzyme complex, in response to Fc gamma receptor crosslinking or integrin-mediated neutrophil adhesion, both of which cause an increase in (Ca2+)i (95). The mechanism by which Ca2+ regulates NOX2 activation is not well understood but has been suggested to involve PKC, PI3K and sphingosine kinase (96, 97). In the human neutrophil-like cell line HL-60 and in primary human neutrophils SOCE mediated by ORAI1 and STIM1 (but not STIM2) is necessary for phagosomal ROS production (91, 98). Furthermore, neutrophil recruitment to sites of inflammation required chemokine and beta 2-integrin signaling, both of which induced an increase in (Ca2+)i (95, 99, 100). It has recently been shown that the Beta 2 integrin-mediated transition of neutrophils from a rolling state to an arrested state is dependent on SOCE mediated by ORAI1 (90). Whether SOCE is required for neutrophil migration in vivo remains to be studied. Non-store operated Ca2+ channels such as the Ca2+ permeable channel TRPM2 also contribute to neutrophil trafficking resulting in impaired CXCL2 chemokine ligand-dependent neutrophil migration to the colon of Trpm2-/- mice in a rodent model of IBD (101). In summary, neutrophils require Ca2+ signals for several of their effector functions including phagocytosis, ROS production and migration and SOCE emerges to be an important pathway mediating Ca2+ influx in these cells.
4. IMMUNE DEFICIENCIES ASSOCIATED WITH DEFECTS in SOCE
SOCE in immune cells depends on a series of signaling events that include the engagement of antigen receptors (such as the TCR, BCR and FcR), the depletion of ER Ca2+ stores and the STIM- and ORAI-dependent activation of CRAC channels. Other ion channels such as K+ channels indirectly control SOCE by generating a negative membrane potential and enabling Ca2+ influx along an electrical gradient. We here focus on defects in genes linking antigen receptor stimulation to Ca2+ store depletion and in the CRAC channel genes ORAI1 and STIM1.
4.1. Mutations in immunoreceptor-associated genes upstream of store-depletion
In T and B cells, mutations in the signaling molecules ZAP-70 (Zeta-chain-associated protein kinase), ITK (IL-2-inducible T cell kinase), BTK (Bruton's tyrosine kinase) and BLNK (B cell linker protein) have been described in immunodeficient patients. Mutations in these genes are associated with impaired lymphocyte signal transduction, Ca2+ store depletion and SOCE. ZAP-70 links phosphorylation of the TCR zeta chain to the phosphorylation of LAT (Linker of activated T cells) and the assembly of a scaffold protein complex that is required for PLC gamma (phospholipase C) activation and IP3 production. Mutations in ZAP-70 cause Severe Combined Immunodeficiency (SCID), which is due to a selective defect in the development of CD8+ T cells and impaired activation of CD4+ T cells. SOCE in ZAP-70-deficient T cells isolated from the blood of patients was found to be impaired in response to TCR stimulation (but not, as expected, ionomycin treatment) (102). A similar defect is observed in Zap70-/- mice, which have a more severe defect in T cell development and lack both CD4+ and CD8+ T cells (103).
Following ZAP-70 activation, tyrosine kinases of the Tec family such as ITK (in T cells) and BTK (in B cells) are recruited into signaling complexes with the scaffold proteins SLP-76 (SH2 domain containing leukocyte protein) and BLNK. ITK and BTK mediate the phosphorylation of PLC gamma 1 and PLC gamma 2 in T and B cells, respectively, and thus regulate IP3 production and store depletion. ITK-deficient patients have normal T cell numbers but fail to control infection with Epstein Barr virus (EBV) (104). Itk-/- mice showed reduced numbers of immature T cells in the thymus (105) and CD4+ T cells in the blood (106) as well as a defect in T cell activation (105). T cells from ITK-deficient patients were not analyzed for SOCE but T cells from Itk-/- mice showed reduced SOCE upon TCR crosslinking (106, 107). Ca2+ influx is also severely impaired in immature pre-B cells isolated from the bone marrow of patients with BTK gene mutations and in B cells from Btk-/- mice following BCR crosslinking (108). A similar defect in SOCE is observed in B cells from Blnk-/- mice (109). BTK- and BLNK-deficient patients suffer from Agammaglobulinemia due to severe defects in B cell maturation (110) (111). The defect in B cell development has been attributed to impaired signaling through the pre-BCR complex, which is required for survival of immature B cells.
In addition, targeted deletion of signaling molecules that link TCR stimulation to store depletion in murine T cells such as SLP-76, LAT and PLC gamma 1 severely impairs SOCE, T cell function and T cell development (112-114). Taken together, these data from human immunodeficient patients and knockout mice demonstrate that signaling pathways regulating SOCE in lymphocytes are critical for T and B cell function. They also suggested that SOCE in response to antigen receptor stimulation may be required for lymphocyte development. This idea was further supported by the observation of Ca2+ signals in immature lymphocytes (40, 41). As will be discussed in the next section, however, SOCE is not - at least not SOCE mediated by STIM1, STIM2 and ORAI1 proteins - required for T and B cell development (16, 33, 34, 38, 66).
4.2. Mutations in CRAC channel genes ORAI1 and STIM1
Since the discovery of STIM1 and ORAI1 as critical mediators of SOCE in 2005 and 2006, respectively, patients with defects in CRAC channel function and mutations in ORAI1 and STIM1 genes have been identified that provide the most direct insight into the physiological role of SOCE in humans in vivo. These patients lack CRAC channel function and SOCE in a variety of cell types and suffer from a unique genetic syndrome ("CRAC channelopathy") that is defined by immunodeficiency, autoimmunity, ectodermal dysplasia and myopathy (5, 27, 29, 35). The mutations and phenotype of these patients have been described in detail elsewhere (5, 27, 115) and we here provide a brief, updated overview of critical findings in these patients.
4.2.1. Mutations in ORAI1
Inherited mutations in ORAI1 are rare and only six patients with autosomal recessive mutations in the coding region of ORAI1 are known to date (Table 2). Positional cloning in two patients and healthy members of one family with CRAC channel deficiency has let to the identification of a missense mutation in ORAI1 that causes a single amino acid substitution, R91W, which is located at the cytoplasmic end of the first transmembrane (TM) domain of ORAI1 (11). Whereas ORAI1 mRNA and protein expression were normal in cells from these patients, SOCE and CRAC channel function were abolished in T cells (11, 61). The R91W mutation in ORAI1 is likely to abolish CRAC channel function by interfering with channel gating or by constricting the permeation pathway of the channel. Substitution of R91 with the hydrophobic amino acid tryptophan (W) and, alternatively, leucine (L), valine (V) or phenylalanine (F) inhibited CRAC channel function, whereas replacement of R91 with neutral or negatively charged amino acids had no effect on ICRAC (116) (S.Feske, M. Prakriya unpublished). This effect was explained by an increase in the transmembrane probability of TM1 and thus presumably a more stable insertion of TM1 in the plasma membrane bilayer when R91 is replaced with a hydrophobic residue (116).
Patients from two other families, by contrast, had null mutations in ORAI1 and lacked ORAI1 protein expression (Table 2). Insertion of an adenine nucleotide in the coding sequence of ORAI1 in two siblings born to consanguineous parents resulted in a frameshift, premature termination of ORAI1 translation and abolished ORAI1 mRNA and protein expression (ORAI1-A88SfsX25) (29, 58). Two siblings from a third family were born to unrelated parents and were compound heterozygous for two missense mutations (A103E, L194P) in TM1 and TM3 that interfered with stable ORAI1 protein expression (29, 42). Lack of ORAI1 expression in cells of patients from the last two families completely abolished SOCE (29, 42, 58) suggesting that endogenously expressed ORAI2 and ORAI3, which are detectable at the mRNA level in many immune cells including T and B cells, monocytes and neutrophils (30), fail to substitute for ORAI1. In addition, ectopic expression of ORAI2 and ORAI3 in T cells or fibroblasts from ORAI1-R91W-deficient patients also failed to rescue SOCE (28). Patients with mutations in ORAI2 or ORAI3 have not been reported so far and the role of these channel isoforms in immune cells and their function remains to be determined.
It is noteworthy that heterozygosity for all reported ORAI1 mutations in relatives of the patients was not associated with clinical symptoms in general and infections in particular. At the cellular level, however, T cells from individuals heterozygous for the R91W mutation had reduced SOCE at subphysiological extracellular (Ca2+)o (0.2 - 0.5 mM) (11). By contrast, SOCE in T cells from individuals heterozygous for the A103E and L194P mutations was comparable to that in healthy controls under similar recording conditions (29). These findings suggest that the R91W mutation has a dominant negative effect on CRAC channel function, presumably through the assembly of the non-functional ORAI1 subunit into the tetrameric channel complex. This idea is supported by the finding that one mutant ORAI1-R91W subunit, when forced into a tetrameric configuration with wildtype ORAI1 subunits in the context of a concatenated tetramer, was sufficient to reduce ICRAC by ~ 50%; two mutant subunits abolished ICRAC (117). Under non-concatenated conditions, however, heterozygous expression of mutant ORAI1-R91W reduced ICRAC in T cells from the patients relatives by only ~ 50-70% (36), failed to impair SOCE at physiological (Ca2+)o (11) and did not cause increased susceptibility to infections. Taken together, these findings indicate that monoallelic expression of ORAI1 is sufficient to support normal SOCE and immune function (29).
4.2.2. Mutations in STIM1
Autosomal recessive mutations in STIM1 are rare and to date only four patients from two families have been reported (Table 2) (35, 59). Insertion of an adenine nucleotide in exon 3 of STIM1 resulted in a frameshift and premature termination at position 136 (E128RfsX9) in siblings of one family (35). No full-length or truncated STIM1 protein was detected in cells from these patients. A patient from a second family was homozygous for a G>A substitution in the splice acceptor site of STIM1 exon 8 (1,538-1G>A). Normally spliced, full-length STIM1 mRNA transcripts and STIM1 protein were completely absent in the patient's B cells. As a consequence, SOCE in response to Ca2+ store depletion with thapsigargin was undetectable in B cells from this patient and fibroblasts from patients with the E128RfsX9 mutation (35, 59). While SOCE could be restored in fibroblasts from STIM1-deficient patients by overexpression of STIM1 and, interestingly, also STIM2 (35). Endogenous STIM2 levels and function, however, are insufficient in human patients to rescue SOCE and immune function. Taken together, the mutations in ORAI1 and STIM1 in immunodeficient patients and the resulting lack of SOCE suggest that both genes are responsible for the majority of SOCE in immune cells whereas STIM2, ORAI2 and ORAI3 play a minor role.
4.3. Clinical manifestations of ORAI1 and STIM1 deficiency
4.3.1. Immunodeficiency and autoimmunity
Mutations in ORAI1 and STIM1 that abolish SOCE and CRAC channel function result in a very similar
clinical phenotype suggesting that both genes act in the same pathway. The disease is characterized by a constellation of symptoms that is unique to CRAC channelopathy and is dominated by immunodeficiency with recurrent infections early in live, autoimmunity, hypohidrotic ectodermal dysplasia (HED) and muscular dysplasia. Infections are caused by a variety of bacterial, fungal and viral pathogens, especially herpes viruses such as cytomegalovirus (CMV), Epstein-Barr Virus (EBV), varizella zoster virus and human herpes virus 8 (HHV8). The latter caused disseminated Kaposi sarcoma (KS) in a patient with a STIM1 splice site mutation (1,538-1G>A) when she was two years old (59, 118). The spectrum of infections and their first occurrence early in life is similar to infections observed in patients with Severe Combined Immunodeficiency (SCID), who lack T and/or B cells, although opportunistic infections such as P. jirovecii pneumonia have not been observed in CRAC channel-deficient patients. As is the case for SCID patients, hematopoietic stem cell transplantation (HSCT) is the only cure for patients with CRAC channelopathy.
In addition to immunodeficiency, patients with mutations in STIM1, and to a lesser degree those with mutations in ORAI1, suffer from lymphadenopathy, hepatosplenomegaly and symptoms of autoimmune disease (29, 35). All four STIM1-deficient patients suffered from autoimmune hemolytic anemia and thrombocytopenia (35), whereas only one of six ORAI1-deficient patients showed autoimmune thrombocytopenia and neutropenia (29). Autoimmunity in STIM1-deficient patients is likely due to a reduction in the total number of Foxp3+ regulatory T cells (Treg) (35), a subpopulation of CD4+ T cells. One of their main functions is to restrict the activation of potentially autoreactive T cells (as discussed in more detail in Chapter 3.2). A similar phenotype of lymphoproliferation with splenomegaly and lymphadenopathy was observed in mice with T-cell specific deletion of Stim1 and Stim2 genes, which show a severe defect in the development and function of Treg cells (16). By contrast, mice lacking only Stim1 expression in T cells have normal numbers of Treg cells (16, 34). It is not understood why only mice lacking both STIM1 and STIM2 have impaired Treg development and autoinflammatory disease, whereas in human patients STIM1 deficiency alone is sufficient to cause a similar phenotype. A possible explanation is that STIM2 may contribute significantly to SOCE in murine, but not human Treg cells.
The immunopathology in ORAI1- and STIM1-deficient patients is due to impaired activation of T cells, NK cells and potentially other cell types in the immune system. By contrast, no defect in lymphocyte development (with the exception of CD4+ Foxp3+ regulatory T cells as described above) has been observed. All patients with mutations in ORAI1 and STIM1 had normal leukocyte numbers and subpopulations. In particular, the numbers of CD4+ and CD8+ T cells, B cell and NK cells were comparable to healthy controls (29, 35), which is in contrast to most forms of SCID in which T, B and/or NK cell development is impaired depending on the underlying gene defect (110). Altogether, these findings argue against an important role of ORAI1, STIM1 and most likely SOCE itself for lymphocyte development, especially since normal T, B and NK cell development has also been observed in mice lacking Orai1, Stim1, Stim2 and Stim1/Stim2 gene expression (16, 34, 36-39, 66). In contrast to normal lymphocyte development, the activation of T and NK cells was severely impaired in the absence of SOCE. T cells failed to proliferate in response to TCR and mitogen stimulation with anti-CD3 antibodies and PHA, ConA or PMA / ionomycin, respectively. In addition, SOCE-deficient CD4+ and CD8+ T cells showed severely impaired expression of multiple cytokines such as IL-2, IL4, IL-10, IFN gamma and TNF alpha (62, 63). The patients' T cell function was also compromised in vivo as no delayed-type hypersensitivity responses to intraepidermal challenges with recall antigens could be observed (58, 62). As discussed in chapter 3, CD8+ T cells and NK cells from ORAI1- and STIM1-deficient patients showed severe defects in degranulation and cell-mediated cytotoxicity of tumor cells (60). The function of SOCE-deficient B cells appears to be unimpaired as serum concentrations of IgG, IgA and IgM were normal or elevated in ORAI1- and STIM1-deficient patients. Patient B cells stimulated with pokeweek mitogen in vitro produced normal amounts of IgG and IgA, although IgM levels were moderately reduced (119). Taken together, B cells appear to be able to differentiate into Ig producing plasma cells and to produce antibodies in the absence of SOCE, which is confirmed by recent findings in STIM1- and STIM2-deficient B cells in mice (66).
4.3.2. Non-immunological symptoms of SOCE deficiency
The non-immunological features of CRAC channelopathy in human patients have been described in detail elsewhere (27, 29, 35). They are dominated by a generalized muscular hypotonia and hypohidrotic ectodermal dysplasia (HED). Muscular hypotonia is present from birth in ORAI1- and STIM1-deficient patients and represents a severe clinical problem in those patients surviving after HSCT (29, 35, 60). The patients not only suffer from a generalized muscle weakness and impaired endurance; in addition they developed bronchiectases with respiratory insufficiency, potentially due to impaired respiratory muscle function. A muscle biopsy in one patient with ORAI1-R91W mutation revealed an atrophy of type II muscle fibers as the cause of the muscular hypotonia. It is of note that Orai1KI/KI mice (which are homozygous for the equivalent ORAI1-R93W mutation) did not display significant histological or ultrastructural abnormalities of their skeletal muscles (36). This is in contrast to STIM1-deficient mice, whose muscle fibers had reduced diameters, displayed signs of mitochondriopathy and fatigued more quickly than those of wildtype controls (120). The latter finding suggests that SOCE is required for refilling of SR calcium stores and muscle fiber contraction. Taken together, the studies in ORAI1- and STIM1-deficient patients and mice illustrate the important role of SOCE in skeletal muscle function and differentiation.
The ectodermal dysplasia in ORAI1- and STIM1-deficient patients is characterized by a severe defect in dental enamel calcification. This finding suggests that CRAC channels may be required for mediating vectorial Ca2+ transport in ameloblasts, which is necessary for the deposition of Ca2+ in the enamel extracellular space (121). ORAI1- and, to a lesser degree, STIM1- deficient patients have impaired sweat production resulting in dry skin and heat intolerance. This defect is most likely due to the impaired function of eccrine sweat glands as anion secretion in sweat glands was reported to be regulated by Ca2+ influx (122, 123). Further studies are required to elucidate the role of ORAI1 and STIM1 in regulating SOCE and the function of eccrine sweat glands, ameloblasts and myocytes.
5. CONCLUSIONS
Following the identification of STIM and ORAI proteins as critical mediators of SOCE, there has been an exponential growth in studies exploring the role of SOCE and STIM/ORAI proteins in many cellular processes including the function of immune cells. Mutations in STIM1 and ORAI1 genes are linked to primary immunodeficiency in patients, illustrating the critical role of STIM1 and ORAI1 in immune responses to infection, especially those mediated by T cells. Furthermore, an increasing number of studies have explored STIM/ORAI-mediated SOCE and its function in lymphoid and myeloid immune cells. The picture emerging from these studies is that ORAI1, STIM1 and their homologues mediate SOCE in many immune cells and that they are essential for many cell-type specific effector functions. While SOCE does not appear to be important for the development of immune cells (with the exception of regulatory T cells), it is indispensable for effector functions of immune cells such as CD4+ effector and regulatory T cells, cytotoxic CD8+ T cells and NK cells, mast cells and neutrophils. However, the majority of the data identifying a critical role for SOCE in cellular immune function is derived from cell lines and in vitro experiments, and therefore the significance of SOCE for immune responses in vivo remains unknown. The emerging role of ORAI and STIM proteins in SOCE and the function of immune cells in both the adaptive and innate immune system begins to explain, however, the complex immune phenotype observed in STIM1- and ORAI1-deficient patients. Future studies will have to investigate how SOCE regulates, for instance, immunity to infection with viral and bacterial pathogens as well as inflammatory and allergic immune responses. Results from these experiments will provide a mechanistic basis to assess the potential for therapeutic immunomodulation through SOCE inhibition in inflammatory and autoimmune diseases.
6. ACKNOWLEDGEMENTS
This work was funded by NIH grant AI066128 to SF.
7. REFERENCES
|
1.D. E. Clapham: Calcium signaling. Cell, 131(6), 1047-58 (2007) |
| doi:10.1016/j.cell.2007.11.028 |
|
2.S. Feske: Calcium signalling in lymphocyte activation and disease. Nat Rev Immunol, 7(9), 690-702 (2007) doi:nri2152 (pii)
|
| doi:10.1038/nri2152 |
|
3.M. Oh-hora: Calcium signaling in the development and function of T-lineage cells. Immunol Rev, 231(1), 210-24 (2009) doi:IMR819 (pii)
|
| doi:10.1111/j.1600-065X.2009.00819.x |
|
4.M. Vig and J. P. Kinet: Calcium signaling in immune cells. Nat Immunol, 10(1), 21-7 (2009) doi:ni.f.220 (pii)
|
| doi:10.1038/ni.f.220 |
|
5.S. Feske: ORAI1 and STIM1 deficiency in human and mice: roles of store-operated Ca2+ entry in the immune system and beyond. Immunol Rev, 231(1), 189-209 (2009) |
| doi:10.1111/j.1600-065X.2009.00818.x |
|
6.J. W. Putney, Jr.: A model for receptor-regulated calcium entry. Cell Calcium, 7(1), 1-12 (1986) |
| doi:10.1016/0143-4160(86)90026-6 |
|
7.H. Takemura, A. R. Hughes, O. Thastrup and J. W. Putney, Jr.: Activation of calcium entry by the tumor promoter thapsigargin in parotid acinar cells. Evidence that an intracellular calcium pool and not an inositol phosphate regulates calcium fluxes at the plasma membrane. J Biol Chem, 264(21), 12266-71 (1989) |
|
8.M. Hoth and R. Penner: Depletion of intracellular calcium stores activates a calcium current in mast cells. Nature, 355(6358), 353-6 (1992) |
| doi:10.1038/355353a0 |
|
9.R. S. Lewis and M. D. Cahalan: Mitogen-induced oscillations of cytosolic Ca2+ and transmembrane Ca2+ current in human leukemic T cells. Cell Regul, 1(1), 99-112 (1989) |
|
10.A. Zweifach and R. S. Lewis: Mitogen-regulated Ca2+ current of T lymphocytes is activated by depletion of intracellular Ca2+ stores. Proc Natl Acad Sci USA, 90(13), 6295-9 (1993) |
| doi:10.1073/pnas.90.13.6295 |
|
11.S. Feske, Y. Gwack, M. Prakriya, S. Srikanth, S. H. Puppel, B. Tanasa, P. G. Hogan, R. S. Lewis, M. Daly and A. Rao: A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature, 441(7090), 179-85 (2006) doi:nature04702 (pii)
|
| doi:10.1038/nature04702 |
|
12.J. Roos, P. J. DiGregorio, A. V. Yeromin, K. Ohlsen, M. Lioudyno, S. Zhang, O. Safrina, J. A. Kozak, S. L. Wagner, M. D. Cahalan, G. Velicelebi and K. A. Stauderman: STIM1, an essential and conserved component of store-operated Ca2+ channel function. J Cell Biol, 169(3), 435-45 (2005) doi:jcb.200502019 (pii)
|
| doi:10.1083/jcb.200502019 |
|
13.J. Liou, M. L. Kim, W. D. Heo, J. T. Jones, J. W. Myers, J. E. Ferrell, Jr. and T. Meyer: STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ influx. Curr Biol, 15(13), 1235-41 (2005) doi:S0960-9822(05)00570-1 (pii)
|
| doi:10.1016/j.cub.2005.05.055 |
|
14.M. Vig, C. Peinelt, A. Beck, D. L. Koomoa, D. Rabah, M. Koblan-Huberson, S. Kraft, H. Turner, A. Fleig, R. Penner and J. P. Kinet: CRACM1 is a plasma membrane protein essential for store-operated Ca2+ entry. Science, 312(5777), 1220-3 (2006) doi:1127883 (pii)
|
| doi:10.1126/science.1127883 |
|
15.S. L. Zhang, A. V. Yeromin, X. H. Zhang, Y. Yu, O. Safrina, A. Penna, J. Roos, K. A. Stauderman and M. D. Cahalan: Genome-wide RNAi screen of Ca(2+) influx identifies genes that regulate Ca(2+) release-activated Ca(2+) channel activity. Proc Natl Acad Sci U S A, 103(24), 9357-62 (2006) doi:0603161103 (pii)
|
| doi:10.1073/pnas.0603161103 |
|
16.M. Oh-Hora, M. Yamashita, P. G. Hogan, S. Sharma, E. Lamperti, W. Chung, M. Prakriya, S. Feske and A. Rao: Dual functions for the endoplasmic reticulum calcium sensors STIM1 and STIM2 in T cell activation and tolerance. Nat Immunol, 9(4), 432-43 (2008) doi:ni1574 (pii)
|
| doi:10.1038/ni1574 |
|
17.J. Liou, M. Fivaz, T. Inoue and T. Meyer: Live-cell imaging reveals sequential oligomerization and local plasma membrane targeting of stromal interaction molecule 1 after Ca2+ store depletion. Proc Natl Acad Sci U S A, 104(22), 9301-6 (2007) doi:0702866104 (pii)
|
| doi:10.1073/pnas.0702866104 |
|
18.P. B. Stathopulos, L. Zheng and M. Ikura: Stromal interaction molecule (STIM) 1 and STIM2 calcium sensing regions exhibit distinct unfolding and oligomerization kinetics. J Biol Chem, 284(2), 728-32 (2009) doi:C800178200 (pii)
|
|
19.O. Brandman, J. Liou, W. S. Park and T. Meyer: STIM2 is a feedback regulator that stabilizes basal cytosolic and endoplasmic reticulum Ca2+ levels. Cell, 131(7), 1327-39 (2007) doi:S0092-8674(07)01543-7 (pii)
|
| doi:10.1016/j.cell.2007.11.039 |
|
20.R. E. Dolmetsch, R. S. Lewis, C. C. Goodnow and J. I. Healy: Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature, 386(6627), 855-8 (1997) doi:10.1038/386855a0 |
| doi:10.1038/386855a0 |
|
21.M. Prakriya, S. Feske, Y. Gwack, S. Srikanth, A. Rao and P. G. Hogan: Orai1 is an essential pore subunit of the CRAC channel. Nature, 443(7108), 230-3 (2006) doi:nature05122 (pii)
|
| doi:10.1038/nature05122 |
|
22.M. Vig, A. Beck, J. M. Billingsley, A. Lis, S. Parvez, C. Peinelt, D. L. Koomoa, J. Soboloff, D. L. Gill, A. Fleig, J. P. Kinet and R. Penner: CRACM1 multimers form the ion-selective pore of the CRAC channel. Curr Biol, 16(20), 2073-9 (2006) doi:S0960-9822(06)02153-1 (pii)
|
| doi:10.1016/j.cub.2006.08.085 |
|
23.A. V. Yeromin, S. L. Zhang, W. Jiang, Y. Yu, O. Safrina and M. D. Cahalan: Molecular identification of the CRAC channel by altered ion selectivity in a mutant of Orai. Nature, 443(7108), 226-9 (2006) doi:nature05108 (pii)
|
| doi:10.1038/nature05108 |
|
24.B. A. McNally, M. Yamashita, A. Engh and M. Prakriya: Structural determinants of ion permeation in CRAC channels. Proc Natl Acad Sci U S A, 106(52), 22516-21 (2009) doi:0909574106 (pii)
|
| doi:10.1073/pnas.0909574106 |
|
25.Y. Zhou, S. Ramachandran, M. Oh-Hora, A. Rao and P. G. Hogan: Pore architecture of the ORAI1 store-operated calcium channel. Proc Natl Acad Sci U S A, 107(11), 4896-901 (2010) doi:1001169107 (pii)
|
| doi:10.1073/pnas.1001169107 |
|
26.R. T. Williams, S. S. Manji, N. J. Parker, M. S. Hancock, L. Van Stekelenburg, J. P. Eid, P. V. Senior, J. S. Kazenwadel, T. Shandala, R. Saint, P. J. Smith and M. A. Dziadek: Identification and characterization of the STIM (stromal interaction molecule) gene family: coding for a novel class of transmembrane proteins. Biochem J, 357(Pt 3), 673-85 (2001) |
| doi:10.1042/0264-6021:3570673 |
|
27.S. Feske: CRAC channelopathies. Pflugers Arch, 460(2), 417-35 (2010) doi:10.1007/s00424-009-0777-5 |
| doi:10.1007/s00424-009-0777-5 |
|
28.Y. Gwack, S. Srikanth, S. Feske, F. Cruz-Guilloty, M. Oh-hora, D. S. Neems, P. G. Hogan and A. Rao: Biochemical and functional characterization of Orai proteins. J Biol Chem, 282(22), 16232-43 (2007) doi:M609630200 (pii)
|
| doi:10.1074/jbc.M609630200 |
|
29.C. A. McCarl, C. Picard, S. Khalil, T. Kawasaki, J. Rother, A. Papolos, J. Kutok, C. Hivroz, F. Ledeist, K. Plogmann, S. Ehl, G. Notheis, M. H. Albert, B. H. Belohradsky, J. Kirschner, A. Rao, A. Fischer and S. Feske: ORAI1 deficiency and lack of store-operated Ca2+ entry cause immunodeficiency, myopathy, and ectodermal dysplasia. J Allergy Clin Immunol, 124(6), 1311-1318 e7 (2009) doi:S0091-6749(09)01533-4 (pii)
|
| doi:10.1016/j.jaci.2009.10.007 |
|
30.BioGPS: http://biogps.gnf.org. In, |
|
31.J. T. Smyth, S. Y. Hwang, T. Tomita, W. I. DeHaven, J. C. Mercer and J. W. Putney: Activation and regulation of store-operated calcium entry. J Cell Mol Med, 14(10), 2337-49 (2010) doi:JCMM1168 (pii)
|
| doi:10.1111/j.1582-4934.2010.01168.x |
|
32.P. G. Hogan, R. S. Lewis and A. Rao: Molecular basis of calcium signaling in lymphocytes: STIM and ORAI. Annu Rev Immunol, 28, 491-533 (2010) doi:10.1146/annurev.immunol.021908.132550 |
| doi:10.1146/annurev.immunol.021908.132550 |
|
33.J. Ma, C. A. McCarl, S. Khalil, K. Luthy and S. Feske: T-cell specific deletion of STIM1 and STIM2 protects mice from EAE by impairing the effector functions of Th1 and Th17 cells. Eur J Immunol, In press (2010) |
| doi:10.1002/eji.201040614 |
|
34.N. Beyersdorf, A. Braun, T. Vogtle, D. Varga-Szabo, R. R. Galdos, S. Kissler, T. Kerkau and B. Nieswandt: STIM1-independent T cell development and effector function in vivo. J Immunol, 182(6), 3390-7 (2009) doi:182/6/3390 (pii)
|
| doi:10.4049/jimmunol.0802888 |
|
35.C. Picard, C. A. McCarl, A. Papolos, S. Khalil, K. Luthy, C. Hivroz, F. LeDeist, F. Rieux-Laucat, G. Rechavi, A. Rao, A. Fischer and S. Feske: STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. N Engl J Med, 360(19), 1971-80 (2009) |
| doi:10.1056/NEJMoa0900082 |
|
36.C. A. McCarl, S. Khalil, J. Ma, M. Oh-hora, M. Yamashita, J. Roether, T. Kawasaki, A. Jairaman, Y. Sasaki, M. Prakriya and S. Feske: Store-operated Ca2+ entry through ORAI1 is critical for T cell-mediated autoimmunity and allograft rejection. J Immunol, 185(10), 5845-58 (2010) doi:jimmunol.1001796 (pii)
|
| doi:10.4049/jimmunol.1001796 |
|
37.Y. Baba, K. Nishida, Y. Fujii, T. Hirano, M. Hikida and T. Kurosaki: Essential function for the calcium sensor STIM1 in mast cell activation and anaphylactic responses. Nat Immunol, 9(1), 81-8 (2008) doi:ni1546 (pii)
|
|
38.Y. Gwack, S. Srikanth, M. Oh-Hora, P. G. Hogan, E. D. Lamperti, M. Yamashita, C. Gelinas, D. S. Neems, Y. Sasaki, S. Feske, M. Prakriya, K. Rajewsky and A. Rao: Hair loss and defective T- and B-cell function in mice lacking ORAI1. Mol Cell Biol, 28(17), 5209-22 (2008) doi:10.1128/MCB.00360-08
|
| doi:10.1128/MCB.00360-08 |
|
39.M. Vig, W. I. DeHaven, G. S. Bird, J. M. Billingsley, H. Wang, P. E. Rao, A. B. Hutchings, M. H. Jouvin, J. W. Putney and J. P. Kinet: Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release-activated calcium channels. Nat Immunol, 9(1), 89-96 (2008) doi:ni1550 (pii)
|
|
40.I. Aifantis, F. Gounari, L. Scorrano, C. Borowski and H. Von Boehmer: Constitutive pre-TCR signaling promotes differentiation through Ca2+ mobilization and activation of NF-kappaB and NFAT. Nat Immunol, 2(5), 403-9 (2001) |
|
41.N. R. Bhakta, D. Y. Oh and R. S. Lewis: Calcium oscillations regulate thymocyte motility during positive selection in the three-dimensional thymic environment. Nat Immunol, 6(2), 143-51 (2005) |
|
42.F. Le Deist, C. Hivroz, M. Partiseti, C. Thomas, H. A. Buc, M. Oleastro, B. Belohradsky, D. Choquet and A. Fischer: A primary T-cell immunodeficiency associated with defective transmembrane calcium influx. Blood, 85(4), 1053-62 (1995) |
|
43.A. R. Youssef, C. Otley, P. W. Mathieson and R. M. Smith: Role of CD4+ and CD8+ T cells in murine skin and heart allograft rejection across different antigenic desparities. Transpl Immunol, 13(4), 297-304 (2004) doi:S0966-3274(04)00110-8 (pii)
|
| doi:10.1016/j.trim.2004.10.005 |
|
44.C. L. Maynard and C. T. Weaver: Intestinal effector T cells in health and disease. Immunity, 31(3), 389-400 (2009) doi:S1074-7613(09)00370-7 (pii)
|
| doi:10.1016/j.immuni.2009.08.012 |
|
45.J. Zhu, H. Yamane and W. E. Paul: Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol, 28, 445-89 (2010) doi:10.1146/annurev-immunol-030409-101212 |
| doi:10.1146/annurev-immunol-030409-101212 |
|
46.M. K. Schuhmann, D. Stegner, A. Berna-Erro, S. Bittner, A. Braun, C. Kleinschnitz, G. Stoll, H. Wiendl, S. G. Meuth and B. Nieswandt: Stromal interaction molecules 1 and 2 are key regulators of autoreactive T cell activation in murine autoimmune central nervous system inflammation. J Immunol, 184(3), 1536-42 (2010) doi:jimmunol.0902161 (pii)
|
| doi:10.4049/jimmunol.0902161 |
|
47.Y. K. Lee, H. Turner, C. L. Maynard, J. R. Oliver, D. Chen, C. O. Elson and C. T. Weaver: Late developmental plasticity in the T helper 17 lineage. Immunity, 30(1), 92-107 (2009) doi:S1074-7613(08)00546-3 (pii) |
| doi:10.1016/j.immuni.2008.11.005 |
|
48.L. Zhou, M. M. Chong and D. R. Littman: Plasticity of CD4+ T cell lineage differentiation. Immunity, 30(5), 646-55 (2009) doi:S1074-7613(09)00198-8 (pii)
|
| doi:10.1016/j.immuni.2009.05.001 |
|
49.L. Codarri, G. Gyulveszi, V. Tosevski, L. Hesske, A. Fontana, L. Magnenat, T. Suter and B. Becher: RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat Immunol (2011) doi:ni.2027 (pii)
|
| doi:10.1038/ni.2027 |
|
50.M. El-Behi, B. Ciric, H. Dai, Y. Yan, M. Cullimore, F. Safavi, G. X. Zhang, B. N. Dittel and A. Rostami: The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat Immunol (2011) doi:ni.2031 (pii)
|
| doi:10.1038/ni.2031 |
|
51.S. Sakaguchi, M. Miyara, C. M. Costantino and D. A. Hafler: FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol, 10(7), 490-500 (2010) doi:nri2785 (pii)
|
| doi:10.1038/nri2785 |
|
52.S. Sakaguchi, T. Yamaguchi, T. Nomura and M. Ono: Regulatory T cells and immune tolerance. Cell, 133(5), 775-87 (2008) doi:S0092-8674(08)00624-7 (pii)
|
| doi:10.1016/j.cell.2008.05.009 |
|
53.H. D. Ochs, S. F. Ziegler and T. R. Torgerson: FOXP3 acts as a rheostat of the immune response. Immunol Rev, 203, 156-64 (2005) doi:IMR231 (pii)
|
|
54.M. E. Brunkow, E. W. Jeffery, K. A. Hjerrild, B. Paeper, L. B. Clark, S. A. Yasayko, J. E. Wilkinson, D. Galas, S. F. Ziegler and F. Ramsdell: Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet, 27(1), 68-73 (2001) doi:10.1038/83784 |
| doi:10.1038/83784 |
|
55.H. Arase, E. S. Mocarski, A. E. Campbell, A. B. Hill and L. L. Lanier: Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science, 296(5571), 1323-6 (2002) doi:10.1126/science.1070884
|
| doi:10.1126/science.1070884 |
|
56.H. R. Smith, J. W. Heusel, I. K. Mehta, S. Kim, B. G. Dorner, O. V. Naidenko, K. Iizuka, H. Furukawa, D. L. Beckman, J. T. Pingel, A. A. Scalzo, D. H. Fremont and W. M. Yokoyama: Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A, 99(13), 8826-31 (2002) doi:10.1073/pnas.092258599 092258599 (pii) |
|
57.O. Mandelboim, N. Lieberman, M. Lev, L. Paul, T. I. Arnon, Y. Bushkin, D. M. Davis, J. L. Strominger, J. W. Yewdell and A. Porgador: Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature, 409(6823), 1055-60 (2001) doi:10.1038/35059110 |
| doi:10.1038/35059110 |
|
58.M. Partiseti, F. Le Deist, C. Hivroz, A. Fischer, H. Korn and D. Choquet: The calcium current activated by T cell receptor and store depletion in human lymphocytes is absent in a primary immunodeficiency. J Biol Chem, 269(51), 32327-35 (1994) |
|
59.M. Byun, A. Abhyankar, V. Lelarge, S. Plancoulaine, A. Palanduz, L. Telhan, B. Boisson, C. Picard, S. Dewell, C. Zhao, E. Jouanguy, S. Feske, L. Abel and J. L. Casanova: Whole-exome sequencing-based discovery of STIM1 deficiency in a child with fatal classic Kaposi sarcoma. J Exp Med, 207(11), 2307-12 (2010) doi:jem.20101597 (pii)
|
| doi:10.1084/jem.20101597 |
|
60.A. Maul-Pavicic, S. C. Chiang, A. Rensing-Ehl, B. Jessen, C. Fauriat, S. M. Wood, S. Sjoqvist, M. Hufnagel, I. Schulze, T. Bass, W. W. Schamel, S. Fuchs, H. Pircher, C. A. McCarl, K. Mikoshiba, K. Schwarz, S. Feske, Y. T. Bryceson and S. Ehl: ORAI1-mediated calcium influx is required for human cytotoxic lymphocyte degranulation and target cell lysis. Proc Natl Acad Sci U S A, 108(8), 3324-9 (2011) doi:1013285108 (pii)
|
| doi:10.1073/pnas.1013285108 |
|
61.S. Feske, M. Prakriya, A. Rao and R. S. Lewis: A severe defect in CRAC Ca2+ channel activation and altered K+ channel gating in T cells from immunodeficient patients. J Exp Med, 202(5), 651-62 (2005) doi:jem.20050687 (pii)
|
| doi:10.1084/jem.20050687 |
|
62.S. Feske, J. M. Muller, D. Graf, R. A. Kroczek, R. Drager, C. Niemeyer, P. A. Baeuerle, H. H. Peter and M. Schlesier: Severe combined immunodeficiency due to defective binding of the nuclear factor of activated T cells in T lymphocytes of two male siblings. Eur J Immunol, 26(9), 2119-26 (1996) doi:10.1002/eji.1830260924 |
| doi:10.1002/eji.1830260924 |
|
63.S. Feske, J. Giltnane, R. Dolmetsch, L. M. Staudt and A. Rao: Gene regulation mediated by calcium signals in T lymphocytes. Nat Immunol, 2(4), 316-24 (2001) doi:10.1038/86318 |
|
64.J. Goto, A. Z. Suzuki, S. Ozaki, N. Matsumoto, T. Nakamura, E. Ebisui, A. Fleig, R. Penner and K. Mikoshiba: Two novel 2-aminoethyl diphenylborinate (2-APB) analogues differentially activate and inhibit store-operated Ca(2+) entry via STIM proteins. Cell Calcium, 47(1), 1-10 (2010) doi:S0143-4160(09)00172-9 (pii)
|
| doi:10.1016/j.ceca.2009.10.004 |
|
65.A. T. Pores-Fernando and A. Zweifach: Calcium influx and signaling in cytotoxic T-lymphocyte lytic granule exocytosis. Immunol Rev, 231(1), 160-73 (2009) doi:IMR809 (pii)
|
| doi:10.1111/j.1600-065X.2009.00809.x |
|
66.M. Matsumoto, Y. Fujii, A. Baba, M. Hikida, T. Kurosaki and Y. Baba: The Calcium Sensors STIM1 and STIM2 Control B Cell Regulatory Function through Interleukin-10 Production. Immunity, 34(1-12) (2011) |
| doi:10.1016/j.immuni.2011.03.016 |
|
67.T. Morita, A. Tanimura, Y. Baba, T. Kurosaki and Y. Tojyo: A Stim1-dependent, noncapacitative Ca2+-entry pathway is activated by B-cell-receptor stimulation and depletion of Ca2+. J Cell Sci, 122(Pt 8), 1220-8 (2009) doi:122/8/1220 (pii)
|
| doi:10.1242/jcs.041640 |
|
68.S. Fillatreau, C. H. Sweenie, M. J. McGeachy, D. Gray and S. M. Anderton: B cells regulate autoimmunity by provision of IL-10. Nat Immunol, 3(10), 944-50 (2002) doi:10.1038/ni833
|
| doi:10.1038/ni833 |
|
69.A. Limnander, P. Depeille, T. S. Freedman, J. Liou, M. Leitges, T. Kurosaki, J. P. Roose and A. Weiss: STIM1, PKC-delta and RasGRP set a threshold for proapoptotic Erk signaling during B cell development. Nat Immunol, 12(5), 425-33 (2011) doi:ni.2016 (pii)
|
| doi:10.1038/ni.2016 |
|
70.S. F. Connolly and D. J. Kusner: The regulation of dendritic cell function by calcium-signaling and its inhibition by microbial pathogens. Immunol Res, 39(1-3), 115-27 (2007) doi:IR:39:1-3:115 (pii) |
| doi:10.1007/s12026-007-0076-1 |
|
71.B. J. Czerniecki, C. Carter, L. Rivoltini, G. K. Koski, H. I. Kim, D. E. Weng, J. G. Roros, Y. M. Hijazi, S. Xu, S. A. Rosenberg and P. A. Cohen: Calcium ionophore-treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells. J Immunol, 159(8), 3823-37 (1997) |
|
72.G. K. Koski, G. N. Schwartz, D. E. Weng, R. E. Gress, F. H. Engels, M. Tsokos, B. J. Czerniecki and P. A. Cohen: Calcium ionophore-treated myeloid cells acquire many dendritic cell characteristics independent of prior differentiation state, transformation status, or sensitivity to biologic agents. Blood, 94(4), 1359-71 (1999) |
|
73.N. Matzner, I. M. Zemtsova, T. X. Nguyen, M. Duszenko, E. Shumilina and F. Lang: Ion channels modulating mouse dendritic cell functions. J Immunol, 181(10), 6803-9 (2008) doi:181/10/6803 (pii) |
|
74.S. Hsu, P. J. O'Connell, V. A. Klyachko, M. N. Badminton, A. W. Thomson, M. B. Jackson, D. E. Clapham and G. P. Ahern: Fundamental Ca2+ signaling mechanisms in mouse dendritic cells: CRAC is the major Ca2+ entry pathway. J Immunol, 166(10), 6126-33 (2001) |
|
75.B. C. Bandyopadhyay, S. C. Pingle and G. P. Ahern: Store-operated Ca(2)+ signaling in dendritic cells occurs independently of STIM1. J Leukoc Biol, 89(1), 57-62 (2011) doi:jlb.0610381 (pii)
|
| doi:10.1189/jlb.0610381 |
|
76.R. Malaviya, T. Ikeda, E. Ross and S. N. Abraham: Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature, 381(6577), 77-80 (1996) doi:10.1038/381077a0 |
| doi:10.1038/381077a0 |
|
77.J. S. Marshall, C. A. King and J. D. McCurdy: Mast cell cytokine and chemokine responses to bacterial and viral infection. Curr Pharm Des, 9(1), 11-24 (2003) |
| doi:10.2174/1381612033392413 |
|
78.M. Leslie: Mast cells show their might. Science, 317(5838), 614-6 (2007) doi:317/5838/614 (pii)
|
| doi:10.1126/science.317.5838.614 |
|
79.Z. Hajkova, V. Bugajev, E. Draberova, S. Vinopal, L. Draberova, J. Janacek and P. Draber: STIM1-directed reorganization of microtubules in activated mast cells. J Immunol, 186(2), 913-23 (2011) doi:jimmunol.1002074 (pii)
|
| doi:10.4049/jimmunol.1002074 |
|
80.A. Braun, J. E. Gessner, D. Varga-Szabo, S. N. Syed, S. Konrad, D. Stegner, T. Vogtle, R. E. Schmidt and B. Nieswandt: STIM1 is essential for Fcgamma receptor activation and autoimmune inflammation. Blood, 113(5), 1097-104 (2009) doi:blood-2008-05-158477 (pii)
|
|
81.B. C. Chen, C. F. Chou and W. W. Lin: Pyrimidinoceptor-mediated potentiation of inducible nitric-oxide synthase induction in J774 macrophages. Role of intracellular calcium. J Biol Chem, 273(45), 29754-63 (1998) |
| doi:10.1074/jbc.273.45.29754 |
|
82.H. Tapper: The secretion of preformed granules by macrophages and neutrophils. J Leukoc Biol, 59(5), 613-22 (1996) |
|
83.N. Watanabe, J. Suzuki and Y. Kobayashi: Role of calcium in tumor necrosis factor-alpha production by activated macrophages. J Biochem, 120(6), 1190-5 (1996) |
|
84.D. J. Kusner and J. A. Barton: ATP stimulates human macrophages to kill intracellular virulent Mycobacterium tuberculosis via calcium-dependent phagosome-lysosome fusion. J Immunol, 167(6), 3308-15 (2001) |
|
85.Z. A. Malik, G. M. Denning and D. J. Kusner: Inhibition of Ca(2+) signaling by Mycobacterium tuberculosis is associated with reduced phagosome-lysosome fusion and increased survival within human macrophages. J Exp Med, 191(2), 287-302 (2000) |
| doi:10.1084/jem.191.2.287 |
|
86.I. Vergne, J. Chua and V. Deretic: Tuberculosis toxin blocking phagosome maturation inhibits a novel Ca2+/calmodulin-PI3K hVPS34 cascade. J Exp Med, 198(4), 653-9 (2003) doi:10.1084/jem.20030527 jem.20030527 (pii) |
| doi:10.1084/jem.20030527 |
|
87.S. Zimmerli, M. Majeed, M. Gustavsson, O. Stendahl, D. A. Sanan and J. D. Ernst: Phagosome-lysosome fusion is a calcium-independent event in macrophages. J Cell Biol, 132(1-2), 49-61 (1996) |
| doi:10.1083/jcb.132.1.49 |
|
88.R. Jayachandran, V. Sundaramurthy, B. Combaluzier, P. Mueller, H. Korf, K. Huygen, T. Miyazaki, I. Albrecht, J. Massner and J. Pieters: Survival of mycobacteria in macrophages is mediated by coronin 1-dependent activation of calcineurin. Cell, 130(1), 37-50 (2007) doi:S0092-8674(07)00664-2 (pii)
|
| doi:10.1016/j.cell.2007.04.043 |
|
89.J. C. Edberg, C. T. Lin, D. Lau, J. C. Unkeless and R. P. Kimberly: The Ca2+ dependence of human Fc gamma receptor-initiated phagocytosis. J Biol Chem, 270(38), 22301-7 (1995) |
| doi:10.1074/jbc.270.38.22301 |
|
90.U. Y. Schaff, N. Dixit, E. Procyk, I. Yamayoshi, T. Tse and S. I. Simon: Orai1 regulates intracellular calcium, arrest, and shape polarization during neutrophil recruitment in shear flow. Blood, 115(3), 657-66 (2010) doi:blood-2009-05-224659 (pii)
|
| doi:10.1182/blood-2009-05-224659 |
|
91.N. Steinckwich, V. Schenten, C. Melchior, S. Brechard and E. J. Tschirhart: An essential role of STIM1, Orai1, and S100A8-A9 proteins for Ca2+ signaling and Fc(gamma)R-mediated phagosomal oxidative activity. J Immunol, 186(4), 2182-91 (2011) doi:jimmunol.1001338 (pii)
|
| doi:10.4049/jimmunol.1001338 |
|
92.D. P. Lew, T. Andersson, J. Hed, F. Di Virgilio, T. Pozzan and O. Stendahl: Ca2+-dependent and Ca2+-independent phagocytosis in human neutrophils. Nature, 315(6019), 509-11 (1985) |
| doi:10.1038/315509a0 |
|
93.S. W. Edwards, F. Watson, L. Gasmi, D. A. Moulding and J. A. Quayle: Activation of human neutrophils by soluble immune complexes: role of Fc gamma RII and Fc gamma RIIIb in stimulation of the respiratory burst and elevation of intracellular Ca2+. Ann N Y Acad Sci, 832, 341-57 (1997) |
| doi:10.1111/j.1749-6632.1997.tb46262.x |
|
94.K. Kobayashi, K. Takahashi and S. Nagasawa: The role of tyrosine phosphorylation and Ca2+ accumulation in Fc gamma-receptor-mediated phagocytosis of human neutrophils. J Biochem, 117(6), 1156-61 (1995) |
|
95.D. B. Graham, C. M. Robertson, J. Bautista, F. Mascarenhas, M. J. Diacovo, V. Montgrain, S. K. Lam, V. Cremasco, W. M. Dunne, R. Faccio, C. M. Coopersmith and W. Swat: Neutrophil-mediated oxidative burst and host defense are controlled by a Vav-PLCgamma2 signaling axis in mice. J Clin Invest, 117(11), 3445-52 (2007) doi:10.1172/JCI32729 |
| doi:10.1172/JCI32729 |
|
96.V. Schenten, C. Melchior, N. Steinckwich, E. J. Tschirhart and S. Brechard: Sphingosine kinases regulate NOX2 activity via p38 MAPK-dependent translocation of S100A8/A9. J Leukoc Biol, 89(4), 587-96 (2011) doi:jlb.0510304 (pii)
|
| doi:10.1189/jlb.0510304 |
|
97.S. Brechard, A. Salsmann and E. J. Tschirhart: OAG induces an additional PKC-, PI3K-, and Rac2-mediated signaling pathway up-regulating NOX2 activity, independently of Ca2+ entry. J Leukoc Biol, 85(4), 638-47 (2009) doi:jlb.0508330 (pii)
|
| doi:10.1189/jlb.0508330 |
|
98.S. Brechard, S. Plancon, C. Melchior and E. J. Tschirhart: STIM1 but not STIM2 is an essential regulator of Ca2+ influx-mediated NADPH oxidase activity in neutrophil-like HL-60 cells. Biochem Pharmacol, 78(5), 504-13 (2009) doi:S0006-2952(09)00370-0 (pii)
|
|
99.C. Hellberg, L. Molony, L. Zheng and T. Andersson: Ca2+ signalling mechanisms of the beta 2 integrin on neutrophils: involvement of phospholipase C gamma 2 and Ins(1,4,5)P3. Biochem J, 317 ( Pt 2), 403-9 (1996) |
|
100.W. Schorr, D. Swandulla and H. U. Zeilhofer: Mechanisms of IL-8-induced Ca2+ signaling in human neutrophil granulocytes. Eur J Immunol, 29(3), 897-904 (1999) doi:10.1002/(SICI)1521-4141(199903)29:03<897::AID-IMMU897>3.0.CO;2-5 (pii)
|
| doi:10.1002/(SICI)1521-4141(199903)29:03<897::AID-IMMU897>3.0.CO;2-5 |
|
101.S. Yamamoto, S. Shimizu, S. Kiyonaka, N. Takahashi, T. Wajima, Y. Hara, T. Negoro, T. Hiroi, Y. Kiuchi, T. Okada, S. Kaneko, I. Lange, A. Fleig, R. Penner, M. Nishi, H. Takeshima and Y. Mori: TRPM2-mediated Ca2+influx induces chemokine production in monocytes that aggravates inflammatory neutrophil infiltration. Nat Med, 14(7), 738-47 (2008) doi:nm1758 (pii)
|
| doi:10.1038/nm1758 |
|
102.A. C. Chan, T. A. Kadlecek, M. E. Elder, A. H. Filipovich, W. L. Kuo, M. Iwashima, T. G. Parslow and A. Weiss: ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. Science, 264(5165), 1599-601 (1994) |
| doi:10.1126/science.8202713 |
|
103.I. Negishi, N. Motoyama, K. Nakayama, S. Senju, S. Hatakeyama, Q. Zhang, A. C. Chan and D. Y. Loh: Essential role for ZAP-70 in both positive and negative selection of thymocytes. Nature, 376(6539), 435-8 (1995) |
| doi:10.1038/376435a0 |
|
104.K. Huck, O. Feyen, T. Niehues, F. Ruschendorf, N. Hubner, H. J. Laws, T. Telieps, S. Knapp, H. H. Wacker, A. Meindl, H. Jumaa and A. Borkhardt: Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation. J Clin Invest, 119(5), 1350-8 (2009) |
| doi:10.1172/JCI37901 |
|
105.X. C. Liao and D. R. Littman: Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk. Immunity, 3(6), 757-769 (1995) |
| doi:10.1016/1074-7613(95)90065-9 |
|
106.K. Q. Liu, S. C. Bunnell, C. B. Gurniak and L. J. Berg: T cell receptor-initiated calcium release is uncoupled from capacitative calcium entry in Itk-deficient T cells. J Exp Med, 187(10), 1721-7 (1998) |
| doi:10.1084/jem.187.10.1721 |
|
107.A. B. Parekh, A. Fleig and R. Penner: The store-operated calcium current I(CRAC): nonlinear activation by InsP3 and dissociation from calcium release. Cell, 89(6), 973-80 (1997) doi:S0092-8674(00)80282-2 (pii) |
| doi:10.1016/S0092-8674(00)80282-2 |
|
108.H. C. Genevier and R. E. Callard: Impaired Ca2+ mobilization by X-linked agammaglobulinaemia (XLA) B cells in response to ligation of the B cell receptor (BCR). Clin Exp Immunol, 110(3), 386-91 (1997) |
| doi:10.1046/j.1365-2249.1997.4581478.x |
|
109.H. Jumaa, B. Wollscheid, M. Mitterer, J. Wienands, M. Reth and P. J. Nielsen: Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor protein SLP-65. Immunity, 11(5), 547-54 (1999) doi:S1074-7613(00)80130-2 (pii) |
| doi:10.1016/S1074-7613(00)80130-2 |
|
110.H. D. Ochs, C. I. E. Smith and J. Puck: Primary immunodeficiency diseases : a molecular and genetic approach. Oxford University Press, New York (2007) |
|
111.Y. Minegishi, J. Rohrer, E. Coustan-Smith, H. M. Lederman, R. Pappu, D. Campana, A. C. Chan and M. E. Conley: An essential role for BLNK in human B cell development. Science, 286(5446), 1954-7 (1999) doi:8048 (pii) |
| doi:10.1126/science.286.5446.1954 |
|
112.J. S. Maltzman, L. Kovoor, J. L. Clements and G. A. Koretzky: Conditional deletion reveals a cell-autonomous requirement of SLP-76 for thymocyte selection. J Exp Med, 202(7), 893-900 (2005) doi:jem.20051128 (pii)
|
| doi:10.1084/jem.20051128 |
|
113.C. L. Sommers, C. S. Park, J. Lee, C. Feng, C. L. Fuller, A. Grinberg, J. A. Hildebrand, E. Lacaná, R. K. Menon, E. W. Shores, L. E. Samelson and P. E. Love: A LAT mutation that inhibits T cell development yet induces lymphoproliferation. Science, 296(5575), 2040-3 (2002) doi:10.1126/science.1069066 |
| doi:10.1126/science.1069066 |
|
114.G. Fu, Y. Chen, M. Yu, A. Podd, J. Schuman, Y. He, L. Di, M. Yassai, D. Haribhai, P. E. North, J. Gorski, C. B. Williams, D. Wang and R. Wen: Phospholipase C{gamma}1 is essential for T cell development, activation, and tolerance. J Exp Med, 207(2), 309-18 (2010) doi:jem.20090880 (pii)
|
| doi:10.1084/jem.20090880 |
|
115.S. Feske, C. Picard and A. Fischer: Immunodeficiency due to mutations in ORAI1 and STIM1. Clin Immunol, 135(2), 169-82 (2010) doi:S1521-6616(10)00013-6 (pii)
|
| doi:10.1016/j.clim.2010.01.011 |
|
116.I. Derler, M. Fahrner, O. Carugo, M. Muik, J. Bergsmann, R. Schindl, I. Frischauf, S. Eshaghi and C. Romanin: Increased hydrophobicity at the N-terminus/membrane interface impairs gating of the SCID-related ORAI1 mutant. Journal of Biological Chemistry, 23 (2009) doi:10.1074/jbc.M808312200 |
| doi:10.1074/jbc.M808312200 |
|
117.J. Thompson, O. Mignen and T. Shuttleworth: The Orai1 Severe Combined Immune Deficiency Mutation and Calcium Release-activated Ca2+ Channel Function in the Heterozygous Condition. Journal of Biological Chemistry, 284(11), 6620-6626 (2008) doi:10.1074/jbc.M808346200 |
| doi:10.1074/jbc.M808346200 |
|
118.G. Sahin, A. Palanduz, G. Aydogan, O. Cassar, A. U. Ertem, L. Telhan, N. Canpolat, E. Jouanguy, C. Picard, A. Gessain, L. Abel, J. L. Casanova and S. Plancoulaine: Classic Kaposi sarcoma in 3 unrelated Turkish children born to consanguineous kindreds. Pediatrics, 125(3), e704-8 (2010) doi:peds.2009-2224 (pii)
|
| doi:10.1542/peds.2009-2224 |
|
119.M. Schlesier, C. Niemeyer, U. Duffner, M. Henschen, R. Tanzi-Fetta, G. Wolff-Vorbeck, R. Drager, M. Brandis and H. H. Peter: Primary severe immunodeficiency due to impaired signal transduction in T cells. Immunodeficiency, 4(1-4), 133-6 (1993) |
|
120.J. Stiber, A. Hawkins, Z. S. Zhang, S. Wang, J. Burch, V. Graham, C. C. Ward, M. Seth, E. Finch, N. Malouf, R. S. Williams, J. P. Eu and P. Rosenberg: STIM1 signalling controls store-operated calcium entry required for development and contractile function in skeletal muscle. Nat Cell Biol, 10(6), 688-97 (2008) doi:ncb1731 (pii)
|
| doi:10.1038/ncb1731 |
|
121.M. J. Hubbard: Calcium transport across the dental enamel epithelium. Crit Rev Oral Biol Med, 11(4), 437-66 (2000) |
| doi:10.1177/10454411000110040401 |
|
122.W. H. Ko, H. C. Chan and P. Y. Wong: Anion secretion induced by capacitative Ca2+ entry through apical and basolateral membranes of cultured equine sweat gland epithelium. The Journal of Physiology, 497 ( Pt 1), 19-29 (1996) |
|
123.K. Sato and F. Sato: Relationship between quin-2 determined cytosolic ( Ca2+) and sweat secretion. Am J Phys, 254, C310-7 (1988) |
Abbreviations: BCR, B cell receptor; CRAC, Ca2+ release activated Ca2+ channel; EAE, experimental autoimmune encephalomyelitis; ER, endoplasmic reticulum; IL, interleukin; IFN, interferon; SOCE, store-operated Ca2+ entry; STIM, stromal interaction molecule; TCR, T cell receptor; Th, T helper
Key Words: Calcium, Ca2+, ORAI1, STIM1, STIM2, CRAC, SOCE, T cell, Lymphocyte, Macrophage, Neutrophil, Immunodeficiency, SCID, Review
Send correspondence to: Stefan Feske, Department of Pathology, New York University Medical Center, 550 First Avenue, SRB 316, New York, NY 10016, USA, Tel: 212-263-9066, Fax: 212-263-8211, E-mail: feskes01@nyumc.org